20 December 2006
Total Voting Rights
Futura Medical plc (AIM: FUM), the AIM-listed pharmaceutical group that develops innovative products for consumer healthcare with expertise in sexual health, today notifies the market, for the purposes of the transitional provisions of the Financial Services Authority's Disclosure and Transparency Rules, that the Company’s total issued share capital at the date of this notice is 55,303,601.
The Company’s issued share capital consists of 55,303,601 ordinary shares of 0.2p each, with one voting right per share. There are no shares held in treasury.
The total number of voting rights in the Company is therefore 55,303,601.
The above figure of 55,303,601 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the Disclosure and Transparency Rules.
For any further information please contact:
Futura Medical plc
James Barder, Chief Executive
+44 (0) 1483 685 670
james.barder@futuramedical.co.uk
www.futuramedical.co.uk
For any media enquiries please contact:
Buchanan Communications Limited
Mark Court
+44 (0) 20 7466 5000
markc@buchanan.uk.com
www.buchanan.uk.com